2023
Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials
Merker V, Thompson H, Wolters P, Buono F, Hingtgen C, Rosser T, Barton B, Barnett C, Smith T, Haberkamp D, McManus M, Baldwin A, Moss I, Röhl C, Martin S. Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials. Clinical Trials 2023, 21: 6-17. PMID: 38140900, PMCID: PMC10922038, DOI: 10.1177/17407745231205577.Peer-Reviewed Original ResearchPatient-reported outcome measuresClinical trialsOutcome measuresNeurofibromatosis 1Cutaneous neurofibromasDistress ScaleOlder adultsFinal consensus recommendationsKey secondary outcomesPatient-reported outcomesPatient-reported changesAppearance concernsSystematic literature searchNontumor manifestationsTreatment sequelaeSecondary outcomesBACKGROUND/Consensus recommendationsPatient's perspectiveTumor volumePatient representativesGood psychometric propertiesOutcome ratingsLiterature searchPlexiform
2022
Preliminary Effectiveness of a Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality: Protocol for a Randomized Controlled Trial
Buono FD, Gleed C, Boldin M, Aviles A, Wheeler N. Preliminary Effectiveness of a Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2022, 11: e30186. PMID: 35029534, PMCID: PMC8800086, DOI: 10.2196/30186.Peer-Reviewed Original ResearchINTERNATIONAL REGISTERED REPORT IDENTIFIERAlcohol use disorderQuality of lifeBlood alcohol concentrationUse disordersAlcohol use disorder populationTreatment providersPsychological distressRandomized clinical trialsLong-term treatmentTreatment motivationCost-effective treatmentControlled TrialsDisease management approachTreatment modalitiesChronic disordersAlcohol concentrationClinical trialsDropout ratePreliminary effectivenessAlcohol dependenceTimely interventionDisorder populationMonthsHigher likelihood